444 Survival of patients with early stages cervical cancer after SLN biopsy without systematic pelvic lymphadenectomy: survival outcomes of the SENTIX prospective single-arm international trial (CEEGOG CX-01; ENGOT-CX2)

Abstract

Introduction/BackgroundThe SENTIX was an international, multicentre, prospective single-arm study on sentinel lymph node (SLN) biopsy without systematic pelvic lymphadenectomy in patients with early-stage cervical cancer. Here, we report the final...